Ravgen and Myriad in patent dispute over DNA testing tech

24-12-2020

Ravgen and Myriad in patent dispute over DNA testing tech

Michael Vi / Shutterstock.com

Biotechnology company Ravgen has accused Myriad Genetics and Myriad Women’s Health of infringing two patents covering non-invasive DNA testing technology.


Ravgen, Myriad Genetics, patent infringement, DNA, genetic screening, prenatal testing, diagnostics, medical technology, biotechnology

LSIPR